tromethamine has been researched along with Esophageal Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asanger, M; Honegger, H; Legay, R; Lukaschek, J; Malet-Martino, M; Martino, R; Maurer, D; Nufer, M; Widmer, L | 1 |
Concannon, MJ; Meng, L; Puckett, CL; Welsh, CF | 1 |
2 other study(ies) available for tromethamine and Esophageal Neoplasms
Article | Year |
---|---|
Cardiotoxicity and neurotoxicity of high-dose continuous fluorouracil as a result of degradation compounds in the drug vials.
Topics: Acetaldehyde; Aged; Antimetabolites, Antineoplastic; Brain Diseases; Carcinoma; Chemistry, Pharmaceutical; Esophageal Neoplasms; Excipients; Fatal Outcome; Female; Fluorouracil; Humans; Hyperammonemia; Male; Malonates; Middle Aged; Rectal Neoplasms; Tromethamine; Ventricular Dysfunction, Left | 2004 |
Inhibition of perioperative platelet aggregation using toradol (ketorolac).
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma, Squamous Cell; Contraindications; Drug Combinations; Esophageal Neoplasms; Esophagoplasty; Female; Humans; Ketorolac Tromethamine; Mandibular Neoplasms; Microsurgery; Middle Aged; Platelet Aggregation; Postoperative Complications; Tolmetin; Tromethamine | 1993 |